drugset / Trial / NCT00832338
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess if docetaxel and cytoxan can shrink the size of your breast tumor and allow you to preserve your breast or have less extensive surgery on your breast. Additionally, by receiving chemotherapy before surgery, the investigators will be able to determine if your cancer is responsive to chemotherapy.
Timeline
- Start
- 2009-04
- Primary completion
- 2015-10
- Completion
- 2015-10
Outcome
Outcome not reported
Stopped (Business): “Funding withdrawn”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 600 mg/m2 | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Background | Dexamethasone | Small molecule | 4 mg | Oral |